Search
Subscribe for $1
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 100 of 100
International
Abbvie looks like dropping Shire bid after crackdown on tax inversions
By
Geoffrey Smith
October 15, 2014
Finance
Valeant seen raising offer for Allergan to clinch deal
By
Geoffrey Smith
October 8, 2014
International
Dallas Ebola patient gets experimental drug
By
TIME
October 7, 2014
International
Ebola outbreak’s impact on 5 key industries
By
Benjamin Snyder
October 3, 2014
International
Salix scraps inversion-based deal to buy Cosmo
By
Reuters
October 3, 2014
Finance
As Ebola spreads, drug companies race to develop treatments
By
Laura Lorenzetti
October 2, 2014
Finance
Stocks roiled by news of first American Ebola case
By
Laura Lorenzetti
October 1, 2014
Finance
J&J buys Alios BioPharma to gain access to infant medicine
By
Laura Lorenzetti
September 30, 2014
Finance
Tax inversion target companies hit by U.S. crackdown
By
Laura Lorenzetti
September 23, 2014
Finance
Merck pays $17 billion for chemical-maker Sigma-Aldrich
By
Laura Lorenzetti
September 22, 2014
Finance
Government benefits, not political pressure, convinced Walgreen to stay stateside
By
Laura Lorenzetti
September 16, 2014
Highest-paid female executive seeks immortality—digitally
By
Robert Hackett
September 12, 2014
Features
How to stop Ebola
By
Erika Fry
September 4, 2014
Retail
CVS stakes its claim in the healthcare market with new name change
By
Laura Lorenzetti
September 3, 2014
Finance
Roche paying $8.3 billion for InterMune and its ‘breakthrough’ respiratory drug
By
Laura Lorenzetti
August 25, 2014
Most Popular
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants...
By
Marco Quiroz-Gutierrez
Success
Jeff Bezos says being lazy, not working hard, is the root of anxiety: ‘The stress goes away the second I take that...
By
Sydney Lake
Commentary
'The Pitt': a masterclass display of DEI in action
By
Robert Raben